Nanoparticles News and Research RSS Feed - Nanoparticles News and Research

UB researchers design nanoparticle that may open door for new 'hypermodal' imaging systems

UB researchers design nanoparticle that may open door for new 'hypermodal' imaging systems

Using two biocompatible parts, University at Buffalo researchers and their colleagues have designed a nanoparticle that can be detected by six medical imaging techniques. [More]
MU's Kattesh Katti named 2015 Hevesy Medal Award winner for contributing to nanomedicine

MU's Kattesh Katti named 2015 Hevesy Medal Award winner for contributing to nanomedicine

Gold nanoparticles have been proven useful in a number of medical applications. Scientists are developing nanoparticles to produce pharmaceuticals used in the imaging and diagnosis of diseases such as cancer, arthritis, Parkinson's disease and eye degeneration. [More]
Researchers invent new imaging system to help detect malignant tissue during surgery

Researchers invent new imaging system to help detect malignant tissue during surgery

With the goal of making it easier for surgeons to detect malignant tissue during surgery and hopefully reduce the rate of cancer recurrence, scientists have invented a new imaging system that causes tumors to "light up" when a hand-held laser is directed at them. [More]
New colloidal gold test strip demonstrates great potential for early detection of heart attack

New colloidal gold test strip demonstrates great potential for early detection of heart attack

NYU Polytechnic School of Engineering professors have been collaborating with researchers from Peking University on a new test strip that is demonstrating great potential for the early detection of certain heart attacks. [More]
Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines

Precision NanoSystems, Arcturus Therapeutics partner to develop RNA medicines

Precision NanoSystems, a leader in the development and application of microfluidics for the manufacture of nanomedicines; and, Arcturus Therapeutics, a leading small interfering RNA (siRNA) and messenger RNA (mRNA) drug discovery and development company, today announced a partnership for the manufacture of RNA medicines. [More]
Exposure to nanoparticles can play major role in development of cardiovascular diseases

Exposure to nanoparticles can play major role in development of cardiovascular diseases

Nanoparticles, extremely tiny particles measured in billionths of a meter, are increasingly everywhere, and especially in biomedical products. Their toxicity has been researched in general terms, but now a team of Israeli scientists has for the first time found that exposure nanoparticles (NPs) of silicon dioxide (SiO2) can play a major role in the development of cardiovascular diseases when the NP cross tissue and cellular barriers and also find their way into the circulatory system. [More]
ProNAi enrolls first patient in PNT2258 Phase II study for treatment of refractory or relapsed DLBCL

ProNAi enrolls first patient in PNT2258 Phase II study for treatment of refractory or relapsed DLBCL

ProNAi Therapeutics Inc., a private hematology/oncology company dedicated to developing and commercializing a new class of therapeutics based on its proprietary DNAi platform, today reported that the first patient with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) has enrolled in the "Wolverine" Phase II study and been treated with PNT2258. [More]
MU researcher developing nano-scale molecules to image, treat different diseases

MU researcher developing nano-scale molecules to image, treat different diseases

Nanomedicine is the medical application of nanotechnology, or the use of microscopic structures to diagnose, image, treat and prevent disease. Current problems in nanomedicine include understanding and anticipating the potentially toxic impact these nanostructures have on the body and the environment once they're released. [More]
Two UT Arlington professors named National Academy of Inventors Fellows

Two UT Arlington professors named National Academy of Inventors Fellows

Two University of Texas at Arlington professors known for their innovation in the world of chemistry have been named Fellows of the National Academy of Inventors. [More]
Laurie T. Krug named Stony Brook University Discovery Prize Fellow

Laurie T. Krug named Stony Brook University Discovery Prize Fellow

Laurie T. Krug, an Assistant Professor in the Department of Molecular Genetics and Microbiology at Stony Brook University, is the first early career scientist to be named Stony Brook University Discovery Prize Fellow, a new philanthropically-sponsored award established to fund high-risk, high-reward basic research projects. [More]
Brunel scientists find way to target hard-to-reach cancers using 'Trojan horse' nanoparticles

Brunel scientists find way to target hard-to-reach cancers using 'Trojan horse' nanoparticles

Scientists at Brunel University London have found a way of targeting hard-to-reach cancers and degenerative diseases using nanoparticles, but without causing the damaging side effects the treatment normally brings. [More]
New light-triggered strategy can provide accurate control over aptamer-based therapeutics

New light-triggered strategy can provide accurate control over aptamer-based therapeutics

While aptamers—single-stranded nucleic acids—offer promise as drug-delivery tools for cancer treatment, it has proven difficult to get them to tumor cells at therapeutic levels. [More]
MIT engineers create new computer model to design complex 3-D DNA shapes

MIT engineers create new computer model to design complex 3-D DNA shapes

MIT biological engineers have created a new computer model that allows them to design the most complex three-dimensional DNA shapes ever produced, including rings, bowls, and geometric structures such as icosahedrons that resemble viral particles. [More]
Therapeutic nanoparticle safe, effective against H. pylori infection, shows study

Therapeutic nanoparticle safe, effective against H. pylori infection, shows study

The bacterium Helicobacter pylori is strongly associated with gastric ulcers and cancer. To combat the infection, researchers at University of California, San Diego School of Medicine and Jacobs School of Engineering developed LipoLLA, a therapeutic nanoparticle that contains linolenic acid, a component in vegetable oils. [More]
Researchers make significant breakthrough for sufferers of bone disease

Researchers make significant breakthrough for sufferers of bone disease

Researchers in bone tissue regeneration believe they have made a significant breakthrough for sufferers of bone trauma, disease or defects such as osteoporosis. [More]
New nanoparticles can simultaneously perform MRI and fluorescent imaging in living animals

New nanoparticles can simultaneously perform MRI and fluorescent imaging in living animals

MIT chemists have developed new nanoparticles that can simultaneously perform magnetic resonance imaging (MRI) and fluorescent imaging in living animals. Such particles could help scientists to track specific molecules produced in the body, monitor a tumor's environment, or determine whether drugs have successfully reached their targets. [More]
WSU researchers working on new system to reduce negative effects of cancer drugs

WSU researchers working on new system to reduce negative effects of cancer drugs

Wichita State University researchers are working on a new system that could decrease the negative effects of cancer drugs on patients. [More]
UNC researchers develop new approach to block KRAS oncogene

UNC researchers develop new approach to block KRAS oncogene

Researchers from the UNC School of Medicine and colleagues at The University of Texas MD Anderson Cancer Center have developed a new approach to block the KRAS oncogene, one of the most frequently mutated genes in human cancer. [More]
Platelet-like nanoparticles mimic human body's coagulation process

Platelet-like nanoparticles mimic human body's coagulation process

Stanching the free flow of blood from an injury remains a holy grail of clinical medicine. Controlling blood flow is a primary concern and first line of defense for patients and medical staff in many situations, from traumatic injury to illness to surgery. [More]
Prof. Dan Peer awarded grant for groundbreaking development in cancer treatment

Prof. Dan Peer awarded grant for groundbreaking development in cancer treatment

Prof. Dan Peer of Tel Aviv University's Department of Cell Research and Immunology will be awarded $10,000 for his groundbreaking development in cancer treatment at the inaugural Untold News Awards on Wednesday, November 12, 2014, from 6:00 to 8:00 p.m. at the Harmonie Club in New York City. [More]